Riskpilot← Back to searchSign inGet full accessØYELEGE AKIL AS
ASActiveOrg 998142067Piggsoppveien 20A, 2016 FrognerMedical specialists activities · NACE 8622Est. 20120 employees
Revenue 2024
NOK 7,4M
+3% vs 2023
EBITDA margin
28.6%
+213% vs 2023
Equity ratio
70.0%
Financial strength
Net profit 2024
NOK 1,8M
+220% vs 2023
| Revenue | NOK 7,4M | +3% |
| EBITDA | NOK 2,1M | +213% |
| Net profit | NOK 1,8M | +220% |
| Total assets | NOK 21,7M | +20% |
| Equity | NOK 15,2M | +13% |
| Employees | 0 | — |
Legal name
ØYELEGE AKIL AS
Org number
998142067
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
12. april 2012
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Øyelegevirksomhet, eiendomsutvikling, kjøp, salg og utleie av boliger og næringseiendom, kjøp og salg av aksjer og deltagelse i andre selskaper, samt all virksomhet som står i forbindelse herved.
Address
Piggsoppveien 20A, 2016 Frogner
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 725 | 6 793 | 6 556 | 7 226 | 7 412 |
| Staff expenses | −1 415 | −1 412 | −1 418 | −1 564 | −1 801 |
| EBITDA | 2 256 | 2 908 | 2 842 | −1 881 | 2 119 |
| Depreciation & amort. | −0 | −0 | −4 | −12 | −10 |
| EBIT | 2 256 | 2 908 | 2 838 | −1 893 | 2 110 |
| Net financials | −80 | 974 | −1 343 | −9 | 162 |
| Profit before tax | 2 176 | 3 883 | 1 495 | −1 902 | 2 272 |
| Tax | 479 | 625 | 615 | −429 | 500 |
| Net profit | 1 697 | 3 257 | 881 | −1 473 | 1 772 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 19 694 | 19 234 | 19 542 | 18 033 | 21 728 |
| Equity | 10 767 | 14 024 | 14 904 | 13 431 | 15 203 |
| Long-term debt | 4 233 | 3 237 | 2 235 | 2 663 | 5 156 |
| Short-term debt | 4 694 | 1 974 | 2 402 | 1 939 | 1 369 |
| Total debt | 8 927 | 5 210 | 4 637 | 4 602 | 6 525 |
EBITDA margin
28.6%
This company
15.8%
Market median
+81% vs market
20202024
Equity ratio
70.0%
This company
38.2%
Market median
+83% vs market
20202024
Return on equity
11.7%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
23.9%
This company
8.1%
Market median
+195% vs market
20202024
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HB Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ØYELEGE AKIL AS 
LØRENSKOG ØYEKLINIKK ASBoard members of ØYELEGE AKIL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hala Binte Saad Syed | Deputy Member | 0 companies |
| Awn Bin Akil Syed | Chairman | 0 companies |